Ardelyx reported $7.12M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Ardelyx USD 7.12M 19.62M Sep/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Curis USD -12.37M 230K Sep/2023
Sanofi EUR 3.74B 2.23B Sep/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024